These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 17465812)
1. ES Cell International & regenerative medicine. Colman A; Alliston D Regen Med; 2006 Mar; 1(2):287-91. PubMed ID: 17465812 [TBL] [Abstract][Full Text] [Related]
2. ES and iPS cell research for cardiovascular regeneration. Yamashita JK Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126 [TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cells and the challenge of transplantation tolerance. Fairchild PJ; Cartland S; Nolan KF; Waldmann H Trends Immunol; 2004 Sep; 25(9):465-70. PubMed ID: 15324738 [TBL] [Abstract][Full Text] [Related]
5. [Regenerative medicine: history and perspectives]. Okabayashi K; Asashima M Nihon Rinsho; 2008 May; 66(5):825-30. PubMed ID: 18464498 [TBL] [Abstract][Full Text] [Related]
6. [Ethical, legal and social issues in regenerative medicine]. Ida R Nihon Rinsho; 2008 May; 66(5):991-6. PubMed ID: 18464522 [TBL] [Abstract][Full Text] [Related]
7. [Establishment of human embryonic stem cell lines and their therapeutic application]. Suemori H Rinsho Byori; 2004 Mar; 52(3):254-8. PubMed ID: 15137326 [TBL] [Abstract][Full Text] [Related]
8. Regenerative cells for transplantation in hepatic failure. Ishikawa T; Banas A; Teratani T; Iwaguro H; Ochiya T Cell Transplant; 2012; 21(2-3):387-99. PubMed ID: 22793046 [TBL] [Abstract][Full Text] [Related]
9. Global challenges in stem cell research and the many roads ahead. Sipp D Neuron; 2011 May; 70(4):573-6. PubMed ID: 21609815 [TBL] [Abstract][Full Text] [Related]
10. Human embryonic stem cells: possibilities for human cell transplantation. Liew CG; Moore H; Ruban L; Shah N; Cosgrove K; Dunne M; Andrews P Ann Med; 2005; 37(7):521-32. PubMed ID: 16278165 [TBL] [Abstract][Full Text] [Related]
12. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry. Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399 [TBL] [Abstract][Full Text] [Related]
13. Embryonic stem (ES) cell-derived cardiomyocytes: a good candidate for cell therapy applications. Pal R Cell Biol Int; 2009 Mar; 33(3):325-36. PubMed ID: 19121644 [TBL] [Abstract][Full Text] [Related]
14. Shifting paradigms? Reflections on regenerative medicine, embryonic stem cells and pharmaceuticals. Wainwright SP; Michael M; Williams C Sociol Health Illn; 2008 Sep; 30(6):959-74. PubMed ID: 18761514 [TBL] [Abstract][Full Text] [Related]
15. Stem cells and regenerative medicine: principles, prospects and problems. Gardner RL C R Biol; 2007; 330(6-7):465-73. PubMed ID: 17631439 [TBL] [Abstract][Full Text] [Related]
16. Human embryonic stem cells: origins, characteristics and potential for regenerative therapy. Mountford JC Transfus Med; 2008 Feb; 18(1):1-12. PubMed ID: 18279188 [TBL] [Abstract][Full Text] [Related]
17. [Ethical and legal issues of regenerative medicine using human ES cells]. Ida R No Shinkei Geka; 2007 Apr; 35(4):403-10. PubMed ID: 17424973 [No Abstract] [Full Text] [Related]